Biliary Tract Cancer - 80 Studies Found
| Completed |
: Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer : Biliary Tract Cancer : 2009-01-29 : Drug: Irinotecan and Gemcitabine |
| Not yet recruiting |
: FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study : Biliary Tract Cancer : 2017-04-07 :
|
| Not yet recruiting |
: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study : Biliary Tract Cancer : 2017-04-07 :
|
| Terminated |
: Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer : Biliary Tract Cancer : 2010-07-27 : Drug: Gemcitabine TS-1 Gemcitabine (1,000mg/m2) will be administered on days 1 and 8 at every 3 weeks TS |
| Recruiting |
: Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC : Biliary Tract Cancer : 2016-12-08 :
|
| Recruiting |
: Ramucirumab for Advanced Pre-treated Biliary Cancers : Biliary Cancer : 2015-08-05 : Drug: Ramucirumab 8 mg/kg by vein on Day 1 of each 14 day cycle. |
| Recruiting |
: A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer :
|
| Recruiting |
: Pembrolizumab and GM-CSF in Biliary Cancer : Biliary Cancer : 2016-03-04 :
|
| Terminated |
: Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer : Biliary Cancer : 2013-01-14 : Drug: SPI-1620 & Docetaxel Patients will receive 11 μg/m2 of SPI-1620 intravenously over one mi |
| Completed |
: Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin : Advanced Biliary Cancer : 2007-10-31 : Drug: Gemox, Cetuximab GEMOX (Arms 1 and 2), every two wee |